Low urinary 6-sulfatoxymelatonin levels in patients with severe congestive heart failure

[1]  D. Cardinali,et al.  Vascular reactivity in diabetic rats: effect of melatonin , 2002, Journal of pineal research.

[2]  M. Dubocovich,et al.  MT(2) melatonin receptors are present and functional in rat caudal artery. , 2002, The Journal of pharmacology and experimental therapeutics.

[3]  M. Møller,et al.  The anatomy and innervation of the mammalian pineal gland , 2002, Cell and Tissue Research.

[4]  A. Wirz-Justice,et al.  Effect of melatonin on vascular responses of porcine ciliary arteries , 2002, Current eye research.

[5]  R. Reiter,et al.  Melatonin suppresses homocysteine enhancement of serotonin‐induced vasoconstriction in the human umbilical artery , 2001, Journal of pineal research.

[6]  H. Girouard,et al.  Vasorelaxant effects of the chronic treatment with melatonin on mesenteric artery and aorta of spontaneously hypertensive rats , 2001, Journal of hypertension.

[7]  D. Cardinali,et al.  Low urinary 6‐sulphatoxymelatonin levels in patients with coronary artery disease , 2000, Journal of pineal research.

[8]  P. Pévet,et al.  Neuropeptide Y increases intracellular calcium in rat pinealocytes , 1999, The European journal of neuroscience.

[9]  V. Csernus,et al.  Adrenergic and peptidergic control of the regulation of cAMP efflux and melatonin secretion from perifused rat pineal gland , 1998, Endocrine.

[10]  D. Cardinali,et al.  Basic aspects of melatonin action. , 1998, Sleep medicine reviews.

[11]  J. Cockrem,et al.  Sulphatoxymelatonin excretion in older people: Relationship to plasma melatonin and renal function , 1998, Journal of pineal research.

[12]  Trevor R. Norman,et al.  The effect of atenolol, a p!‐adrenergic antagonist, on nocturnal plasma melatonin secretion: Evidence for a dose‐response relationship in humans , 1997, Journal of pineal research.

[13]  A. Steiger,et al.  Corticotropin-releasing hormone inhibits melatonin secretion in healthy volunteers--a potential link to low-melatonin syndrome in depression? , 1997, Neuroendocrinology.

[14]  A. Brzezinski.  Melatonin in humans. , 1997, The New England journal of medicine.

[15]  M. Maj,et al.  Pineal response to isoproterenol in rats chronically treated with electroconvulsive shock , 1993, Brain Research Bulletin.

[16]  B. D. Clark,et al.  Endotoxin-induced corticotropin-releasing hormone gene expression in the hypothalamic paraventricular nucleus is mediated centrally by interleukin-1. , 1993, Endocrinology.

[17]  L. B. Weekley.  Effects of melatonin on pulmonary and coronary vessels are exerted through perivascular nerves , 1993, Clinical autonomic research : official journal of the Clinical Autonomic Research Society.

[18]  P. Poole‐Wilson,et al.  Plasma CGRP-like immunoreactivity in treated and untreated congestive heart failure , 1991, The Lancet.

[19]  L. B. Weekley.  Melatonin‐induced relaxation of rat aorta: Interaction with adrenergic agonists , 1991, Journal of pineal research.

[20]  S. Reuss,et al.  The role of arginine-vasopressin for pineal melatonin synthesis in the rat: Involvement of vasopressinergic receptors , 1991, Neuroscience Letters.

[21]  H. Fillit,et al.  Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. , 1990, The New England journal of medicine.

[22]  K. Silberbauer,et al.  Increase in bicycloprostaglandin E2 metabolite in congestive heart failure in response to captopril , 1989, Clinical cardiology.

[23]  D. Cardinali,et al.  In vitro effect of neuropeptide Y on melatonin and norepinephrine release in rat pineal gland , 1987, Cellular and Molecular Neurobiology.

[24]  J. Arendt,et al.  Immunoassay of 6-hydroxymelatonin sulfate in human plasma and urine: abolition of the urinary 24-hour rhythm with atenolol. , 1985, The Journal of clinical endocrinology and metabolism.

[25]  M. Packer,et al.  Prostaglandins in severe congestive heart failure. Relation to activation of the renin--angiotensin system and hyponatremia. , 1984, The New England journal of medicine.

[26]  T. Adrian,et al.  VASOACTIVE INTESTINAL PEPTIDE IN SHOCK AND HEART FAILURE , 1983, The Lancet.

[27]  D. Cardinali,et al.  Role of prostaglandins in rat pineal neuroeffector junction. Changes in melatonin and norepinephrine release in vitro. , 1982, Endocrinology.

[28]  W. Kannel,et al.  The natural history of congestive heart failure: the Framingham study. , 1971, The New England journal of medicine.

[29]  H. Motulsky,et al.  Elevation of plasma neuropeptide Y levels in congestive heart failure. , 1989, The American journal of medicine.

[30]  Vaughan Gm.  Human melatonin in physiologic and diseased states: neural control of the rhythm. , 1986 .